Perioperative Glycemic Management in CABG
The client's blood glucose of
180 mg/dL in the setting of NPO status and mild nausea requires a nuanced response. The priority is not to cancel the surgery or to blindly administer a routine insulin dose, but to communicate the need for a tailored perioperative insulin and monitoring plan.
Why Hyperglycemia Matters Perioperatively
Hospital hyperglycemia, defined as a blood glucose level above
140 mg/dL, is a significant risk factor for adverse surgical outcomes. The physiological stress of surgery triggers a counter-regulatory hormone response (cortisol, catecholamines), promoting hepatic glucose production and insulin resistance. This is compounded by the patient's underlying
type 2 diabetes mellitus. The provided consensus guidelines clearly state that hyperglycemia increases the risk of postoperative complications, particularly
infections,
prolonged hospital stay, and
in-hospital mortality [1]. Ensuring adequate glycemic control during the perioperative period is therefore essential to reduce these risks and improve surgical outcomes
[1].
Analyzing the Options
-
Option 1 (Administer regular morning insulin): This is unsafe without a current order that accounts for the client's NPO status and nausea. Administering a full subcutaneous insulin dose to a patient who is NPO and nauseated could precipitate dangerous
hypoglycemia, a critical safety event.
-
Option 2 (Notify surgeon to cancel surgery): A glucose level of
180 mg/dL is a moderate elevation, not a critical value that typically necessitates cancellation of a necessary procedure like
CABG. The guidelines focus on management, not cancellation, for this level of hyperglycemia [1,2].
-
Option 3 (Continue preparations as acceptable): This is incorrect. A level of
180 mg/dL is above the recommended target range and requires intervention, not passive acceptance. The standard of care dictates active management to mitigate the documented risks of infection and poor wound healing [1,2].
-
Option 4 (Contact physician for insulin coverage and monitoring orders): This is the priority action. It directly addresses the hyperglycemia while ensuring patient safety. The physician can provide a tailored order, often for a correctional dose of rapid-acting insulin or an adjustment to an intravenous insulin infusion protocol, along with a specific frequency for blood glucose monitoring. This aligns with the guideline recommendation for ensuring adequate glycemic control through a structured plan [1,2].
The nurse's role is to recognize that the current glucose level, while not an emergency, is outside the safe target range and requires a collaborative, provider-directed intervention to mitigate perioperative risk. The established standards of care emphasize the necessity of a proactive glycemic management strategy in the hospital setting to prevent complications .
References (research sources)
- [1]
Perioperative screening and management of hyperglycemia: a joint position statement from the Brazilian Diabetes Society (SBD), the Brazilian Society of Anesthesiology (SBA) and the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO).Research articleMarino EC, Negretto LAF, Ribeiro RS, Momesso D, Feitosa ACR, Toyoshima MTK, da Silva Junior JC, Vencio S, Lauria MW, de Sá JR, Malerbi DA, Valente F, Leite SAO, Amaral DEO, Guimarães GMN, da Cunha Leal P, Lopes MB, Salles LCB, de Araújo Azi LMT, Fonseca AG, Carvalho LIM, Coelho FF, Halpern B, Valerio CM, Trujilho FR, Brandão ACA, Lyra R, Bertoluci M. (2026) · DOI: 10.1186/s13098-025-02060-5